通过调节miR-31/NF-κB通路,CRNDE可以缓解IL-1β诱导的慢细胞损伤
Jiuxiang Liu1, Jiangqi Cheng2, Hao Zhou2
1Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), No. 300 Guangzhou Road, NanjingJiangsu Province, 210029, China. liujiuxiang@jsph.org.cn.
Journal of orthopaedic surgery and research
|December 20, 2024
概括
长非编码RNACRNDE通过抑制肌肉细胞中的miR-31和NF-κB通路,减少炎症和软骨损伤,从而防止骨关节炎.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 骨关节炎 (OA) 涉及与年龄相关的关节软骨退化.
- 长非编码RNA的CRNDE与OA病变发生有关.
- 在OA软骨细胞中,CRNDE的精确机制尚未完全理解.
研究的目的:
- 研究CRNDE在OA软骨细胞中的作用.
- 阐明OA中CRNDE的分子机制.
- 确定CRNDE,miR-31和NF-κB通路之间的关系.
主要方法:
- 使用介质素 (IL) - 1β刺激的C-28/I2红细胞来模仿OA炎症.
- 通过RT-PCR评估CRNDE和miR-31表达.
- 评估了细胞活力,细胞亡,炎症性细胞因子水平 (IL-6,IL-1β,TNF-α),软骨矩阵基因表达 (MMP-13,Aggrecan,COL2A1) 和NF-κB通路激活 (p-p65,p-IκBα).
主要成果:
- 在OA组织和IL-1β刺激的胆红细胞中,CRNDE的表达减少.
- 过度表达CRNDE可降低冠状细胞亡,炎症和软骨退化.
- 在OA组织中,miR-31表达较低,与CRNDE负相关.
- miR-31过度表达部分逆转了CRNDE的保护作用.
- 沉默CRNDE恶化IL-1β诱导的胆细胞损伤,这被NF-κB抑制剂减轻.
结论:
- 在OA中,CRNDE可减轻IL-1β诱导的状细胞损伤.
- 通过抑制miR-31介导的NF-κB信号通路来发挥CRNDE的作用.
- CRNDE代表了OA治疗的潜在治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
T Cell Types and Functions
947
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
947
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141


